Lv4
790 积分 2021-12-10 加入
First-in-human Study of a Dual-modality Prostate-specific Membrane Antigen–targeted Probe for Preoperative Positron Emission Tomography/Computed Tomography Imaging and Intraoperative Fluorescence Imaging in Prostate Cancer
2天前
已完结
Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage
3个月前
已完结
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer
5个月前
已完结
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
6个月前
已完结
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
6个月前
已完结
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET—An International Multicenter Retrospective Study
8个月前
已关闭
Real-world prostate-specific antigen response and outcomes in patients with metastatic hormone-sensitive prostate cancer patients treated with apalutamide: a multicentric study
9个月前
已完结
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer
9个月前
已完结
Pembrolizumab for metastatic castration-resistant prostate cancer: trials and tribulations
9个月前
已完结
Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy
9个月前
已完结
皖公网安备34019202002308
